APA aipamena

Kimball, A., Sobell, J., Zouboulis, C., Gu, Y., Williams, D., Sundaram, M., . . . Jemec, G. (2015). HiSCR (Hidradenitis Suppurativa Clinical Response): A novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo‐controlled portion of a phase 2 adalimumab study. J Eur Acad Dermatol Venereol.

Chicago Style aipamena

Kimball, A.B., J.M Sobell, C.C Zouboulis, Y. Gu, D.A Williams, M. Sundaram, H.D Teixeira, and G.B.E Jemec. "HiSCR (Hidradenitis Suppurativa Clinical Response): A Novel Clinical Endpoint to Evaluate Therapeutic Outcomes in Patients With Hidradenitis Suppurativa From the Placebo‐controlled Portion of a Phase 2 Adalimumab Study." J Eur Acad Dermatol Venereol 2015.

MLA aipamena

Kimball, A.B., et al. "HiSCR (Hidradenitis Suppurativa Clinical Response): A Novel Clinical Endpoint to Evaluate Therapeutic Outcomes in Patients With Hidradenitis Suppurativa From the Placebo‐controlled Portion of a Phase 2 Adalimumab Study." J Eur Acad Dermatol Venereol 2015.